Evidences show that non-opioid medications and non-pharmacologic interventions can be effective in treating common types of chronic pain and are considered safer than opioids
Non-opioid Pain Treatment Market: Introduction
- Pain management is an important component of the medical care. Common types of chronic pain conditions are migraine, lower back pain, osteoarthritis, fibromyalgia, localized musculoskeletal pain, and localized neuropathic pain. While opioids may be appropriate for addressing acute or chronic pain relating to palliative or end-of-life care, and active cancer treatment, other non-opioid pain management options are available to treat chronic pain.
- Evidences show that non-opioid medications and non-pharmacologic interventions can be effective in treating common types of chronic pain and are considered safer than opioids
Read Report overview - https://www.transparencymarketresearch.com/non-opioid-pain-treatment-market.html
Key Drivers and Restraints of Global Non-opioid Pain Treatment Market
- The global non-opioid pain treatment market is driven by increasing easy and effective medications of non-opioids drugs for pain treatment, and also their less side-effects and low cost for some treatments
- Opioids have several disadvantages, such as risk of nausea and vomiting, somnolence, androgen deficiency, respiratory depression, constipation, physical dependence, and tolerance. Opioid medications also carry a risk of abuse or addiction by either the patient or non-medical users. For these reasons, consideration of non-opioid strategies for pain management is beneficial. This is fueling the growth of the global non-opoid pain treatment market.
- Better healthcare facilities and availability of sophisticated and novel treatment options, and increasing research and developmental activities related to non-opoid treatment for pain relief are the major factors propelling the growth of the non-opoid pain treatment market
- Increasing geriatric population and rising prevalence of diseases, such as arthritis, cancer, epilepsy, dental disorders, etc., leading to chronic pain conditions, such as, migraine, lower back pain, osteoarthritis, fibromyalgia, localized musculoskeletal pain, and localized neuropathic pain, are fueling the growth of the global non-opioid pain treatment market
- Preference for alternative therapies and fake products, however, are anticipated to restrain the growth of the global non-opioid pain treatment market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74676
Strategies Adopted by Key Players to Offer Attractive Opportunities
- Companies operating in the global non-opioid pain treatment market focus on addressing the needs of the medical communities and patient population by developing effective and novel products. Leading players are engaging in strategies, such as acquisitions, mergers, and collaborations, along with research and developmental activities to strengthen their position in the global market.
- In June 2019, Ironwood Pharmaceuticals and Allergan initiated patient dosing in Phase II Clinical Trial of MD-7246 in patients with abdominal pain associated with IBS-D
- In January 2018, Centrexion Therapeutics raised US$ 67 million and launched Phase 3 program for CNTX-4975 in knee osteoarthritis pain. CNTX-4975, a synthetic, ultra-pure injection of trans-capsaicin for the treatment of chronic pain due to knee osteoarthritis. CNTX-4975 is a highly differentiated, novel, non-opioid therapy designed to be injected directly into the painful joint.
- In June 2018, Sandoz Canada announced that it had finalized its collaboration agreement with Tilray, a Health Canada licensed producer of medical cannabis, allowing Sandoz Canada to become the first Canadian pharmaceutical company to enter the medical cannabis field
- Emerging economies present lucrative opportunities in the non-opioid pain treatment market due to increase in patient population and rise in initiatives by governments in the health care sector
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=74676
North America to Account for Major Share of Global Non-opioid Pain Treatment Market
- North America is projected to capture leading share of the global non-opioid pain treatment market due to health awareness, rise in patient population, a well-established health care infrastructure, increasing research and developmental activities, and presence of key players in the region
- The non-opioid pain treatment market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in patient population, increase in initiatives by governments in the health care sector, surge in incidences of diseases, such as arthritis, cancer, dental disorders, etc., increase in geriatric population, and rise in interest of key players in expanding into the region
Key Players Operating in Global Non-opioid Pain Treatment Market
Leading players in the global non-opioid pain treatment market are focusing on research and development activities. Companies are adopting various growth strategies, including mergers, acquisitions, product upgrades, product launches & approvals, partnerships, and collaborations. Leading players operating in the global non-opioid pain treatment market are:
- Allergan
- Aphria Inc.
- Bedrocan
- Cara Therapeutics
- Centrexion Therapeutics
- Medical Marijuana, Inc.
- Medropharm GmbH
- Panag Pharma Inc.
- Tilray
Request for Discount on this Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=74676
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/